Trinity Capital Provides $50 Million in Growth Capital to Cala Health for Commercial Expansion
Trinity Capital Inc. has committed $50 million in growth capital to Cala Health to support the commercial expansion of its wearable tremor therapy. Cala Health's device, the Cala kIQ® System, is FDA-cleared and designed to help patients manage hand tremors caused by essential tremor and Parkinson's disease. The investment is expected to enhance Cala's ability to expand its commercial reach and product innovation.
Tickers: $TRIN
Topics: bioelectronic medicine Cala Health growth capital investment Trinity Capital Inc.